Sanofi India

Mumbai, India Founded: 1956 • Age: 70 yrs
Manufacturer of pharmaceutical products and vaccines
Annual revenue $234.7M Latest available
Total funding - Funding intelligence
Employees 991 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Sanofi India

Sanofi India is a company based in Mumbai (India) founded in 1956. The company has 991 employees as of December 31, 2024. Sanofi India offers products and services including Vaccines and Diabetes Solutions.

  • Headquarter Mumbai, India
  • Employees 991 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sanofi India Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
    $234.69 M (USD)
    0.81
    as on Dec 31, 2024
  • Net Profit
    $48.25 M (USD)
    -31.45
    as on Dec 31, 2024
  • EBITDA
    $58.53 M (USD)
    -0.16
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    991

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sanofi India

Sanofi India is a publicly listed company on the NSE with ticker symbol SANOFI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: SANOFI · Sector: Health technology · India

Products & Services of Sanofi India

Sanofi India offers a comprehensive portfolio of products and services, including Vaccines and Diabetes Solutions.

Primary

Vaccines are developed and manufactured for disease prevention and are distributed both domestically and internationally.

Medicines for diabetes management are provided as part of the therapy areas addressed by Sanofi.

People of Sanofi India

Headcount 10000+
Employee Profiles 622
Board Members and Advisors 14
Employee Profiles
People
Paul Hudson
Chief Executive Officer
People
Brendan O’Callaghan
EVP, Manufacturing & Supply
People
Edouard Clavel
Finance Business Partner Vaccines France
People
Evgeny Proskurnya
Launch Digital Transformation Program Leader

Unlock access to complete

Board Members and Advisors
people
Christophe Babule
Director
people
Patrick Kron
Director
people
Rachel Duan
Director
people
Barbara Lavernos
Director

Unlock access to complete

Funding Insights of Sanofi India

Investments & Acquisitions by Sanofi India

Investments

Financial Statements - Sanofi India

Sanofi India Comparisons

+
Add Comparison
Available on Premium

Competitors of Sanofi India

Latest news on Sanofi India

Frequently Asked Questions about Sanofi India

Sanofi India was founded in 1956.

Sanofi India is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Dec 31, 2024, the latest employee count at Sanofi India is 991.

Annual revenue of Sanofi India is $234.69M as on Dec 31, 2024.

Manufacturer of pharmaceutical products and vaccines. It produces a variety of dosage forms including tablets, capsules, eyeear drops, and injectables. These products are manufactured to stringent global quality guidelines and are approved by various international regulatory agencies. The company also manufactures products for domestic consumption and export. Its therapeutic areas include diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company utilizes both its own manufacturing facilities and third-party manufacturers.

Sanofi India offers Vaccines and Diabetes Solutions.

Yes, Sanofi India is publicly traded on NSE under the ticker symbol SANOFI.

The ticker symbol of Sanofi India is SANOFI on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available